Clinical significance of monitoring KRAS in tissue and plasma of pancreatic cancer patients

被引：0
|
作者：
Watanabe, Fumiaki
Suzuki, Koichi
Endo, Yuhei
Ishikawa, Hideki
Kakizawa, Nao
Noda, Hiroshi
Rikiyama, Toshiki
机构：
[1] Jichi Med Univ, Saitama, Japan
[2] Jichi Med Univ, Saitama Med Ctr, Saitama, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.254
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
254
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Impact of KRAS mutations in clinical features and survival in pancreatic cancer patients: a single institution experience
    Inga, E.
    Perdomo Zaldivar, E.
    Gomez, M.
    Cano, T.
    Rodriguez Alonso, B.
    Oritz, M.
    Rodriguez Alonso, R.
    Toledano Fonseca, M.
    Rodriguez Ariza, A.
    Aranda, E.
    ANNALS OF ONCOLOGY, 2019, 30
  • [32] PANCREATIC CANCER - CLINICAL OR TISSUE DIAGNOSIS
    LIVSTONE, EM
    GUDJONSSON, B
    SPIRO, HM
    GASTROENTEROLOGY, 1975, 68 (04) : 937 - 937
  • [33] Detection of tumor-associated KRAS mutations in the plasma and tumor tissue of colorectal cancer patients
    Jeffers, Michael
    Pena, Carol
    Henderson, David
    Wilhelm, Scott
    Christensen, Olaf
    Lathia, Chetan
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [34] Clinical significance of stanniocalcin expression in tissue and serum of gastric cancer patients
    Fang, Zheng
    Tian, Zhiqiang
    Luo, Kunlun
    Song, Haizhu
    Yi, Jun
    CHINESE JOURNAL OF CANCER RESEARCH, 2014, 26 (05) : 602 - 610
  • [35] Clinical significance of stanniocalcin expression in tissue and serum of gastric cancer patients
    Zheng Fang
    Zhiqiang Tian
    Kunlun Luo
    Haizhu Song
    Jun Yi
    ChineseJournalofCancerResearch, 2014, 26 (05) : 602 - 610
  • [36] Biological and therapeutic significance of tissue transglutaminase in pancreatic cancer
    K. Mehta
    Amino Acids, 2009, 36
  • [37] Biological and therapeutic significance of tissue transglutaminase in pancreatic cancer
    Mehta, K.
    AMINO ACIDS, 2009, 36 (04) : 709 - 716
  • [38] Clinical significance of dihydropyrimidine dehydrogenase and thymidylate synthase expression in patients with pancreatic cancer
    Osamu Nakahara
    Hiroshi Takamori
    Hiroshi Tanaka
    Yasuo Sakamoto
    Yoshiaki Ikuta
    Satoshi Furuhashi
    Masayuki Watanabe
    Toru Beppu
    Masahiko Hirota
    Keiichiro Kanemitsu
    Hideo Baba
    International Journal of Clinical Oncology, 2010, 15 : 39 - 45
  • [39] Clinical Significance of Serum NEDD9 Levels in Patients with Pancreatic Cancer
    Afsar, Cigdem Usul
    Karabulut, Mehmet
    Karabulut, Senem
    Ozal, Safiye Tokgoz
    Cikot, Murat
    Serilmez, Murat
    Tas, Faruk
    BIOMOLECULES, 2018, 8 (04)
  • [40] Clinical significance of dihydropyrimidine dehydrogenase and thymidylate synthase expression in patients with pancreatic cancer
    Nakahara, Osamu
    Takamori, Hiroshi
    Tanaka, Hiroshi
    Sakamoto, Yasuo
    Ikuta, Yoshiaki
    Furuhashi, Satoshi
    Watanabe, Masayuki
    Beppu, Toru
    Hirota, Masahiko
    Kanemitsu, Keiichiro
    Baba, Hideo
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2010, 15 (01) : 39 - 45
12345